Asia Pacific Neurosurgical Robotics Market 2020-2027 by Product, Equipment Type, End User and Country: Market Size, Share, Forecast and Strategy

Robotic neurosurgery is a fast-growing technology owing to several advantages over the traditional neurology surgery such as better outcomes, increased accuracy, sooner recovery, shorter hospital stay among others.
Asia Pacific neurosurgical robotics market will grow by 20.6% annually with a total addressable market cap of $1,615.3 million over 2021-2027 owing to the growing incidents of neurological diseases, aging population, the improved benefits with robotics-based procedures, and decreasing price of robot-assisted neurology surgery.
Highlighted with 41 tables and 36 figures, this 110-page report “Asia Pacific Neurosurgical Robotics Market 2020-2027 by Product, Equipment Type, End User and Country: Market Size, Share, Forecast and Strategy” is based on a comprehensive research of the entire Asia Pacific neurosurgical robotics market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2017-2019 and provides estimate/forecast from 2020 till 2027 with 2019 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
In-depth qualitative analyses include identification and investigation of the following aspects:
• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter’s Fiver Forces
The trend and outlook of Asia Pacific market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify Asia Pacific neurosurgical robotics market in every aspect of the classification from perspectives of Product, Equipment Type, End User, and Country.

Based on Product, the Asia Pacific market is segmented into the following sub-markets with annual revenue for 2017-2027 included in each section.
• Robotic Systems
• Instruments and Accessories
• System Services

Based on Equipment Type, the Asia Pacific market is segmented into the following sub-markets with annual revenue for 2017-2027 included in each section.
• Robot Machines
• Navigation Systems
• Planners and Simulators
• Other Equipment Types

Based on End User, the Asia Pacific market is segmented into the following sub-markets with annual revenue for 2017-2027 included in each section.
• Hospitals
• Ambulatory Surgical Centers

Geographically, the following national/local markets are fully investigated:
• Japan
• China
• South Korea
• Australia
• India
• Rest of APAC (further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines)
For each key country, detailed analysis and data for annual revenue are available for 2017-2027. The breakdown of key national markets by Product, Equipment Type, and End User over the forecast years are also included.

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Specifically, potential risks associated with investing in Asia Pacific neurosurgical robotics market and industry are assayed quantitatively and qualitatively through GMD’s Risk Assessment System. According to the risk analysis and evaluation, Critical Success Factors (CSFs) are generated as a guidance to help investors & stockholders manage and minimize the risks, develop appropriate business models, and make wise strategies and decisions.
Key Players (this may not be a complete list and extra companies can be added upon request):
Brainlab AG
DePuy Synthes (Johnson & Johnson)
Mazor Robotics Ltd.
Medtronic Inc.
Renishaw plc
Shenzhen Institutes of Advanced Technology (SIAT)
Siemens Healthineers
Simbionix USA Corp.
SONOWAND AS
Stryker Corp. / MAKO
Synaptive Medical, Inc.
Zimmer Biomet Holdings, Inc. / Medtech
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)